← Leaderboards
Yi-Ping Li
Tulane University Of Louisiana
$19,044,938
Attributed
$19,044,938
Total exposure
8
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.5M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$19,044,938 · 8
By mechanism
R01$18,125,600 · 7
RC1$919,338 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- Yiping Chen$15,405,099
- Gary B Baskin$798,496
- Billie B Davison$3,384,826
Others in their field
Top investigators on “Osteoclasts”
- Brendan Hl Lee · Baylor College Of Medicine$18,789,257
- Steven L Teitelbaum · Washington University$16,498,459
- Mone Zaidi · Icahn School Of Medicine At Mount Sinai$16,089,949
- Karl Leonard Insogna · Yale University$15,344,415
- Yongwon Choi · University Of Pennsylvania$14,421,139
- Hong-Wen Deng · Father Flanagan'S Boys'Home$14,176,978
Research focus
OsteoclastsMediatingBaseInsightPhenotypeGenesCellsRegulationSignal TransductionDesignMacrophageGain Of FunctionOverexpressionTissuesOsteolyticMouse ModelMolecularBone ResorptionPathway InteractionsIn VivoInflammatoryInflammationPathologicBone Loss
Grant awards (56)
Mechanistic basis of the role of Cbx3 in negatively regulating osteoclast differentiation through epigenetic modification$480,996
R01 · FY2024 · AR · contact PI
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis$324,368
R01 · FY2024 · AR · contact PI
Mechanistic basis of the role of Cbx3 in negatively regulating osteoclast differentiation through epigenetic modification$495,871
R01 · FY2023 · AR · contact PI
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling$350,296
R01 · FY2023 · DE · contact PI
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis$334,400
R01 · FY2023 · AR · contact PI
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling$349,065
R01 · FY2022 · DE · contact PI
G13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis$349,065
R01 · FY2022 · DE · contact PI
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis$331,053
R01 · FY2022 · AR · contact PI
Mechanistic basis of the role of Cbx3 in negatively regulating osteoclast differentiation through epigenetic modification$480,995
R01 · FY2021 · AR · contact PI
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling$361,000
R01 · FY2021 · DE · contact PI
G13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis$361,000
R01 · FY2021 · DE · contact PI
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in rheumatoid arthritis$300,960
R01 · FY2021 · AR · contact PI
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in Rheumatoid arthritis$22,869
R01 · FY2021 · AR · contact PI
Mechanistic basis of the role of Cbx3 in negatively regulating osteoclast differentiation through epigenetic modification$484,453
R01 · FY2020 · AR · contact PI
Gα13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis$352,688
R01 · FY2020 · DE · contact PI
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling$352,688
R01 · FY2020 · DE · contact PI
Characterizing the negative signaling in dendritic cells and macrophages to attenuate inflammation and bone destruction in Rheumatoid arthritis$326,700
R01 · FY2020 · AR · contact PI
Mechanistic basis of the role of Cbx3 in negatively regulating osteoclast differentiation through epigenetic modification$484,453
R01 · FY2019 · AR · contact PI
Gα13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis$352,688
R01 · FY2019 · DE · contact PI
Inhibiting inflammation and bone erosion in periodontal disease by targeting cell endogenous negative signaling$352,688
R01 · FY2019 · DE · contact PI
Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling$486,605
R01 · FY2018 · DE · contact PI
Gα13 signaling attenuates periodontal inflammation and alveolar bone loss in the mouse model of age-associated periodontitis$352,688
R01 · FY2018 · DE · contact PI
Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling$486,605
R01 · FY2017 · DE · contact PI
Transcriptional Regulation of Osteoclast Lineage Commitment and Differentiation$432,713
R01 · FY2016 · AR · contact PI
Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling$367,500
R01 · FY2016 · DE · contact PI
Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling$82,344
R01 · FY2016 · DE · contact PI
Transcriptional Regulation of Osteoclast Lineage Commitment and Differentiation$432,713
R01 · FY2015 · AR · contact PI
Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling$367,500
R01 · FY2015 · DE · contact PI
Transcriptional Regulation of Osteoclast Lineage Commitment and Differentiation$424,059
R01 · FY2014 · AR · contact PI
Inhibiting Periodontitis by Targeting Cathepsin K and Attenuating TLR Signaling$367,500
R01 · FY2014 · DE · contact PI
Transcriptional Regulation of Osteoclast Lineage Commitment and Differentiation$411,078
R01 · FY2013 · AR · contact PI
Transcriptional Regulation of Osteoclast Lineage Commitment and Differentiation$329,625
R01 · FY2012 · AR · contact PI
Transcriptional Regulation of Osteoclast Lineage Commitment and Differentiation$43,074
R01 · FY2012 · AR · contact PI
Novel RNAi Inhibits Both Inflammation and Bone Resorption in Oral Diseases$461,704
RC1 · FY2010 · DE · contact PI
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression$380,141
R01 · FY2010 · AR · contact PI
Role of RGS10 in Osteoclast Differentiation$210,778
R01 · FY2010 · AR · contact PI
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression$127,150
R01 · FY2010 · AR · contact PI
Role of RGS10 in Osteoclast Differentiation$125,744
R01 · FY2010 · AR · contact PI
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression$76,847
R01 · FY2010 · AR · contact PI
The Role of AML1 in Osteoclastogenesis and Osteoclast Gene Expression$489,000
R01 · FY2009 · AR · contact PI
Novel RNAi Inhibits Both Inflammation and Bone Resorption in Oral Diseases$457,634
RC1 · FY2009 · DE · contact PI
Role of RGS10 in Osteoclast Differentiation$413,829
R01 · FY2009 · AR · contact PI
Role of RGS10 in Osteoclast Differentiation$334,957
R01 · FY2008 · AR · contact PI
Role of RGS10 in Osteoclast Differentiation$341,792
R01 · FY2007 · AR · contact PI
Molecular Mechanisms of Bone Formation$407,343
R01 · FY2006 · AR · contact PI
Role of RGS10 in Osteoclast Differentiation$352,000
R01 · FY2006 · AR · contact PI
Molecular Mechanisms of Bone Formation$417,146
R01 · FY2005 · AR
Molecular Mechanisms of Bone Formation$453,315
R01 · FY2004 · AR
Molecular Mechanisms of Bone Formation$453,315
R01 · FY2003 · AR
Molecular Mechanisms of Bone Formation$453,315
R01 · FY2002 · AR
TRANSCRIPTION FACTORS CONTROL OSTEOCLAST DIFFERENTIATION$348,910
R01 · FY2002 · AR
TRANSCRIPTION FACTORS CONTROL OSTEOCLAST DIFFERENTIATION$40,937
R01 · FY2002 · AR
TRANSCRIPTION FACTORS CONTROL OSTEOCLAST DIFFERENTIATION$339,561
R01 · FY2001 · AR
TRANSCRIPTION FACTORS CONTROL OSTEOCLAST DIFFERENTIATION$97,438
R01 · FY2001 · AR
TRANSCRIPTION FACTORS CONTROL OSTEOCLAST DIFFERENTIATION$322,040
R01 · FY2000 · AR
TRANSCRIPTION FACTORS CONTROL OSTEOCLAST DIFFERENTIATION$107,742
R01 · FY2000 · AR